Investors with a lot of money to spend have taken a bullish stance on DexCom (NASDAQ:DXCM). And retail traders should know. We noticed this today when the positions showed up on publicly available ...
HCPs see CGM as the 'standard of care': Half of all HCPs felt CGM should be the standard of care for people with Type 2 diabetes whether they were using insulin to manage the condition or not. 96% of ...
San Diego, California-based DexCom, Inc. (DXCM ... To confirm the overall bearish trend, DXCM has remained mostly below its 200-day moving average since mid-June 2024 with some fluctuations ...
Zacks Investment Research on MSN6d
DexCom CGM Sensor Sales to Continue Despite FDA Warning LetterDexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback